Cite
HARVARD Citation
Apolo, A. et al. (2020). Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. Lancet oncology. 21 (8), pp. 1099-1109. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Apolo, A. et al. (2020). Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. Lancet oncology. 21 (8), pp. 1099-1109. [Online].